Pure Global
NCT03418753

Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure

Oculogica, Inc.·ClinicalTrials.gov·diagnostic testCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Intracranial Pressure Increase
Drug/Device/Intervention
EyeBOX for ICP
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Oculogica, Inc.
Location
Baltimore,Rochester,Philadelphia, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 10, 2018
End date
May 10, 2023
Enrollment
60 participants
Primary outcome

Sensitivity and Specificity

Summary

The study is a prospective, multi-center, non-randomized, open label observational study. The
 objective of this study is to compare the accuracy of the EyeBOX to a clinical diagnosis of
 abnormal ICP as determined by an external ventriculostomy drain (EVD) or ventriculostomy
 catheter.

ICD-10 classifications
Benign intracranial hypertensionIntracranial injuryIntracranial injury, unspecifiedOther intracranial injuriesIntracranial hypotension following ventricular shunting
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03418753
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT03418753 through Pure Global AI's free database. This phase not specified trial is sponsored by Oculogica, Inc. and is currently Completed. The study focuses on Intracranial Pressure Increase. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.